Literature DB >> 12101224

A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity.

Isabelle Dussault1, Min Lin, Kevin Hollister, Ming Fan, John Termini, Mark A Sherman, Barry M Forman.   

Abstract

Unlike classical nuclear receptors that require ligand for transcriptional activity, the constitutive androstane receptor (CAR) is active in the absence of ligand. To determine the molecular contacts that underlie this constitutive activity, we created a three-dimensional model of CAR and verified critical structural features by mutational analysis. We found that the same motifs that facilitate ligand-dependent activity in classical receptors also mediated constitutive activity in CAR. This raises a critical question: how are these motifs maintained in an active conformation in unliganded CAR? The model identified several novel interactions that account for this activity. First, CAR possesses a short loop between helix 11 and the transactivation domain (helix 12), as well as a short carboxy-terminal helix. Together, these features favor ligand-independent docking of the transactivation domain in a position that is characteristic of ligand-activated receptors. Second, this active conformation is further stabilized by a charge-charge interaction that anchors the carboxy-terminal activation domain to helix 4. Mutational analysis of these interactions provides direct experimental support for this model. We also show that ligand-mediated repression of constitutive activity reflects both a displacement of coactivator and a recruitment of corepressor. Our data demonstrate that CAR utilizes the same conserved structural motifs and coregulator proteins as originally defined for classical nuclear receptors. Despite these remarkable similarities, our model demonstrates how a few critical changes in CAR can dramatically reverse the transcriptional activity of this protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101224      PMCID: PMC133936          DOI: 10.1128/MCB.22.15.5270-5280.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

Review 2.  Coactivator and corepressor complexes in nuclear receptor function.

Authors:  L Xu; C K Glass; M G Rosenfeld
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

3.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

Authors:  S L Anzick; J Kononen; R L Walker; D O Azorsa; M M Tanner; X Y Guan; G Sauter; O P Kallioniemi; J M Trent; P S Meltzer
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.

Authors:  J Torchia; D W Rose; J Inostroza; Y Kamei; S Westin; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

5.  Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

Authors:  H Chen; R J Lin; R L Schiltz; D Chakravarti; A Nash; L Nagy; M L Privalsky; Y Nakatani; R M Evans
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

6.  The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.

Authors:  T A Jackson; J K Richer; D L Bain; G S Takimoto; L Tung; K B Horwitz
Journal:  Mol Endocrinol       Date:  1997-06

7.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

8.  Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR.

Authors:  H S Choi; M Chung; I Tzameli; D Simha; Y K Lee; W Seol; D D Moore
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

9.  RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.

Authors:  H Li; P J Gomes; J D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

10.  GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.

Authors:  H Hong; K Kohli; M J Garabedian; M R Stallcup
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

View more
  42 in total

1.  Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.

Authors:  Behnom Farboud; Herborg Hauksdottir; Yun Wu; Martin L Privalsky
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

2.  CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α.

Authors:  Jie Gao; Jiong Yan; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Endocrinol       Date:  2015-09-25

3.  Modelling approaches for evaluating multiscale tendon mechanics.

Authors:  Fei Fang; Spencer P Lake
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

4.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

5.  Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

Authors:  Li Shan; Jeremy Vincent; Joseph S Brunzelle; Isabelle Dussault; Min Lin; Irina Ianculescu; Mark A Sherman; Barry M Forman; Elias J Fernandez
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

6.  Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity.

Authors:  Björn Windshügel; Johanna Jyrkkärinne; Antti Poso; Paavo Honkakoski; Wolfgang Sippl
Journal:  J Mol Model       Date:  2004-12-23       Impact factor: 1.810

7.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

Review 8.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

Review 9.  A current structural perspective on PXR and CAR in drug metabolism.

Authors:  Cameron D Buchman; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-05-30       Impact factor: 4.481

Review 10.  CAR and PXR: the xenobiotic-sensing receptors.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  Steroids       Date:  2006-12-20       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.